AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 194 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $171 | +6.2% | 21,974 | +31.8% | 0.01% | +12.5% |
| Q2 2023 | $161 | -16.1% | 16,674 | -4.8% | 0.01% | -11.1% |
| Q1 2023 | $192 | +84.6% | 17,510 | -27.2% | 0.01% | +80.0% |
| Q4 2022 | $104 | -99.9% | 24,066 | -12.1% | 0.01% | -58.3% |
| Q3 2022 | $205,000 | -15.3% | 27,377 | +13.6% | 0.01% | -7.7% |
| Q2 2022 | $242,000 | -18.2% | 24,091 | +1.0% | 0.01% | 0.0% |
| Q1 2022 | $296,000 | -58.4% | 23,847 | -23.4% | 0.01% | -53.6% |
| Q4 2021 | $712,000 | +118.4% | 31,135 | +111.3% | 0.03% | +100.0% |
| Q3 2021 | $326,000 | +288.1% | 14,736 | +128.6% | 0.01% | +250.0% |
| Q2 2021 | $84,000 | 0.0% | 6,447 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $84,000 | -7.7% | 6,447 | -2.0% | 0.00% | -20.0% |
| Q4 2020 | $91,000 | -8.1% | 6,576 | -2.3% | 0.01% | -16.7% |
| Q3 2020 | $99,000 | -9.2% | 6,732 | +0.3% | 0.01% | -25.0% |
| Q2 2020 | $109,000 | +9.0% | 6,710 | -3.1% | 0.01% | 0.0% |
| Q1 2020 | $100,000 | – | 6,926 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
| ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
| DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
| NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
| Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
| HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
| SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |